Complement inhibition for the treatment of COVID-19 triggered thrombotic microangiopathy with cardiac failure: a case report

BACKGROUND: Severe coronavirus disease 2019 (COVID-19) has been increasingly recognized as a multisystem disease. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can infect literally any cell type that expresses its target receptor angiotensin-converting enzyme 2. However, COVID-19-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Utebay, Didar, Seeger, Harald, Müller, Antonia M S, David, Sascha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515174/
https://www.ncbi.nlm.nih.gov/pubmed/34661055
http://dx.doi.org/10.1093/ehjcr/ytab386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515174/
https://www.ncbi.nlm.nih.gov/pubmed/34661055
http://dx.doi.org/10.1093/ehjcr/ytab386

Ejemplares similares